What is the recommended management for a peptic ulcer?

Peptic Ulcer Treatment

Treat peptic ulcers with proton pump inhibitors (PPIs) as the primary therapy, test all patients for H. pylori and eradicate if present, and discontinue NSAIDs/aspirin when possible to prevent recurrence and reduce mortality from complications.

Acute Pharmacologic Management

Uncomplicated Peptic Ulcers

• Initiate PPI therapy with standard-dose twice daily (e.g., omeprazole 20-40 mg BID or lansoprazole 30 mg BID) for 4 weeks for duodenal ulcers 1
• Gastric ulcers larger than 2 cm require 8 weeks of PPI treatment to achieve healing rates of 80-100% 1
• After initial healing, discharge patients on once-daily PPI for duration dictated by underlying cause 2

Bleeding Peptic Ulcers with High-Risk Stigmata

• Administer IV PPI as loading dose followed by continuous infusion for 72 hours after successful endoscopic hemostasis (strong recommendation, moderate-quality evidence) 2
• After 72-96 hours of IV PPI, transition to oral PPI twice daily for 14 days, then once daily thereafter 2
• Do not use H2-receptor antagonists for acute ulcer bleeding—they are not recommended 2
• Somatostatin and octreotide are not routinely recommended for acute ulcer bleeding 2

Low-Risk Bleeding Ulcers

• Patients with flat spots or clean-based ulcers do not require intensive PPI therapy and can receive standard once-daily dosing 3

H. Pylori Testing and Eradication

Testing Strategy

• Test all patients with peptic ulcers for H. pylori before discharge 2
• Available tests include urea breath test (sensitivity 88-95%, specificity 95-100%), stool antigen testing (sensitivity 94%, specificity 92%), or endoscopic biopsy 2
• Repeat negative H. pylori tests obtained during acute bleeding, as false negatives occur in the acute setting 2

First-Line Eradication Therapy

Standard triple therapy for 14 days (if local clarithromycin resistance <15%) 2:

• PPI standard dose twice daily
• Clarithromycin 500 mg twice daily
• Amoxicillin 1000 mg twice daily (or Metronidazole 500 mg twice daily if penicillin allergic)

This regimen reduces ulcer recurrence from 50-60% to 0-2% after successful eradication 1

Alternative First-Line: Sequential Therapy

Use 10-day sequential therapy if clarithromycin resistance is high or compliance can be ensured 2:

• Days 1-5: PPI twice daily + Amoxicillin 1000 mg twice daily
• Days 6-10: PPI twice daily + Clarithromycin 500 mg twice daily + Metronidazole 500 mg twice daily

Second-Line Therapy

If first-line therapy fails, use levofloxacin-based triple therapy for 10 days 2:

• PPI standard dose twice daily
• Levofloxacin 500 mg once daily (or 250 mg twice daily)
• Amoxicillin 1000 mg twice daily

Confirmation of Eradication

• Confirm H. pylori eradication after treatment completion 2
• Without eradication, rebleeding rates reach 26% in H. pylori-positive patients 2

NSAID and Antiplatelet Management

NSAID-Induced Ulcers

• Discontinue NSAIDs immediately—this heals 95% of ulcers and reduces recurrence from 40% to 9% 1
• If NSAIDs cannot be discontinued, treat with PPIs during continued NSAID use 4
• When resuming NSAIDs after ulcer healing, use COX-2 inhibitor plus PPI to minimize recurrence risk (this combination is superior to either alone) 2

Low-Dose Aspirin Management

• In patients with established cardiovascular disease who develop ulcer bleeding, restart aspirin within 1-7 days (ideally 1-3 days) once bleeding is controlled, as cardiovascular risk outweighs bleeding risk 2, 3
• Add PPI therapy to all patients on single or dual antiplatelet therapy with previous ulcer bleeding (conditional recommendation, low-quality evidence) 2

Anticoagulant Users

• In patients requiring continued anticoagulation (warfarin or DOACs) with previous ulcer bleeding, use concomitant PPI therapy (conditional recommendation, very low-quality evidence) 2

Endoscopic and Surgical Management

Endoscopic Therapy

• Perform upper endoscopy within 24 hours for diagnosis and risk stratification 3
• Ulcers with active bleeding or non-bleeding visible vessels require endoscopic therapy (bipolar electrocoagulation, heater probe, clips, or sclerosant) 3
• Hospitalize patients for at least 72 hours after endoscopic hemostasis for high-risk stigmata 2

Failed Endoscopic Therapy

• If endoscopic therapy fails, seek surgical consultation immediately 2
• Percutaneous embolization can be considered as an alternative to surgery where available 2
• For recurrent bleeding after initial endoscopic therapy, attempt second endoscopic treatment; if this fails, proceed to surgery or interventional radiology 3

Idiopathic Ulcers

• Patients who are H. pylori-negative and not using NSAIDs have idiopathic peptic ulcers 4, 3
• These patients require long-term PPI therapy to prevent recurrence 3

Common Pitfalls

• Do not rely on negative H. pylori testing during acute bleeding—false negatives are common and testing should be repeated 2
• Avoid premature discontinuation of aspirin in cardiovascular disease patients—the mortality risk from cardiovascular events exceeds bleeding risk in most cases 2
• Do not use single-agent COX-2 inhibitors or PPIs alone in patients with previous ulcer bleeding requiring NSAIDs—combination therapy is necessary 2
• Ensure eradication is confirmed—without documentation, assume treatment failure and retreat 2